Serum triglyceride and apolipoprotein A1 as dynamic biomarkers in extranodal NK/T-cell lymphoma (ENKTL): A multicenter retrospective and prospective validation study.

Saved in:
Bibliographic Details
Title: Serum triglyceride and apolipoprotein A1 as dynamic biomarkers in extranodal NK/T-cell lymphoma (ENKTL): A multicenter retrospective and prospective validation study.
Authors: Wang JN; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Sun Yat- sen University Cancer Center, Guangzhou, P.R. China., Xiong J; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 197 Rui Jin Er Road, Shanghai, P.R. China., Guo HG; Division of Lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, P.R. China., Li ZH; Department of Oncology, Sun Yat-sen Memorial Hospital, Guangzhou, P.R. China., Cao Y; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Sun Yat- sen University Cancer Center, Guangzhou, P.R. China., Fang Y; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Sun Yat- sen University Cancer Center, Guangzhou, P.R. China., Liu YY; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Sun Yat- sen University Cancer Center, Guangzhou, P.R. China., Li YH; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Sun Yat- sen University Cancer Center, Guangzhou, P.R. China., Cai J; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Sun Yat- sen University Cancer Center, Guangzhou, P.R. China., Zhang YC; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Sun Yat- sen University Cancer Center, Guangzhou, P.R. China., Zou QH; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Sun Yat- sen University Cancer Center, Guangzhou, P.R. China., Wang JH; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Sun Yat- sen University Cancer Center, Guangzhou, P.R. China., Xia Y; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Sun Yat- sen University Cancer Center, Guangzhou, P.R. China., Huang HQ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Sun Yat- sen University Cancer Center, Guangzhou, P.R. China., Sun CG; College of Traditional Chinese Medicine, Weifang Medical University, Weifang, P.R. China., Li SQ; Sun Yat-sen University Zhongshan School of Medicine, Guangzhou, P.R. China., Wang L; Department of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing, P.R. China. wangliangtrhos@126.com., Zhao WL; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 197 Rui Jin Er Road, Shanghai, P.R. China., Cai QQ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P.R. China.; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Sun Yat- sen University Cancer Center, Guangzhou, P.R. China.
Source: Annals of hematology [Ann Hematol] 2025 Dec; Vol. 104 (12), pp. 6251-6262. Date of Electronic Publication: 2025 Nov 17.
Publication Type: Journal Article; Multicenter Study; Validation Study
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first